Wegovy Price in 2026: List Cost, Insurance and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

What Wegovy costs at the counter

Wegovy list price runs about $1,349 per month at U.S. list as of April 2026, according to Novo Nordisk's published pricing. That figure is the sticker, not the receipt. What you actually hand over depends on your insurance, the indication your prescription is written for, any manufacturer savings program you qualify for, and the pharmacy filling it. Very few insured patients pay full list.

Browse the full PlexusDx Education Hub library on GLP-1 therapies, weight protocols, and metabolic genetics.

Why insurance changes everything

Coverage hinges on two things: whether the prescription is for an FDA-approved indication and how your specific plan's formulary treats it. Many commercial plans cover semaglutide for type 2 diabetes. Coverage for chronic weight management is spottier and often gated behind prior authorization or BMI-based criteria. The only reliable way to know your number is to ask your plan directly as of April 2026.

Savings cards and pharmacy coupons

The manufacturer card

Novo Nordisk publishes a savings-card program that can meaningfully lower monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility and savings amounts shift over time, so confirm the current terms on the manufacturer's site at the time of fill.

Independent discount platforms

Pharmacy discount services such as GoodRx and SingleCare publish coupon prices that swing by pharmacy and by day. They are worth checking against your card, since the cheaper of the two wins.

The compounding shortage story

Between 2022 and 2024 the FDA listed semaglutide on its drug shortage list, which opened a regulatory lane for licensed 503A compounding pharmacies to prepare semaglutide formulations. The FDA resolved that shortage in 2024, narrowing but not closing the pathway. Where a licensed clinician prescribes through a state-licensed compounding pharmacy, compounded protocols remain a real option, though pricing and access vary widely.

PlexusDx protocols as an alternative

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols, spanning Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. Rather than advertise a single headline rate, each product page lists its own current pricing as of April 2026, so you compare on the specifics.

The genetic layer beneath any price comparison

Before spending on any protocol, there is a cheaper first move: understanding the biology the protocol acts on. That context makes every downstream dollar more deliberate.

Upstream of any GLP-1 decision, the PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants such as FTO, and MC4R that shape your baseline appetite, satiety, and energy-balance biology. It never predicts how you will respond to a specific drug, and it is not a drug-response predictor; it simply gives you the metabolic backdrop to bring into a provider conversation. That is the test-before-you-invest sequence PlexusDx applies to every protocol: understand the biology first, then weigh the options with a clinician rather than guessing. To see the compounded protocols that pair with that context, explore the Weight Management Protocols collection, all delivered through licensed 503A compounding.

How to compare quotes without getting misled

Because the same medication can be quoted at wildly different prices, the useful skill is comparing like with like. A brand list price, an insured copay after a savings card, a pharmacy coupon rate, and a compounded-protocol price are four different things, and lining them up side by side prevents confusion. Ask what a quote actually includes: is it the drug alone, or does it bundle provider evaluation and follow-up? Is it before or after insurance? Is the product FDA-approved brand or a compounded formulation from a licensed pharmacy? Once each figure is labeled correctly, the comparison becomes honest, and the lowest headline figure is not always the most complete offering. It also helps to note when a quote was published, since list prices, savings-card terms, and coupon rates all move over time, and a figure that was accurate last quarter may no longer hold at the counter today.

Frequently Asked Questions

How much does Wegovy cost without insurance?

Wegovy list price is roughly $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Without insurance or a savings card, cash-pay patients face close to that list figure at most pharmacies. Compounded alternatives and discount cards can bring it down.

Is there a coupon or savings card for Wegovy?

Yes. Novo Nordisk publishes a manufacturer savings card that can substantially reduce monthly cost for eligible commercially-insured patients. Independent coupons from GoodRx and SingleCare also publish prices that vary by pharmacy and change frequently, so verify eligibility and terms at the time of fill.

Why is Wegovy so expensive?

It is a patent-protected branded medication, and Novo Nordisk sets list price around R&D recovery, market positioning, and expected payer mix. Prices stayed high in part because demand outpaced manufacturing across 2023 and 2024. Savings programs and compounded alternatives are the main levers patients use.

Are compounded versions cheaper?

Often, yes. Compounded semaglutide from licensed 503A pharmacies has historically priced well below Wegovy list. The trade-offs are regulatory complexity, variation in prescriber oversight, and the FDA's evolving stance on compounding after the 2024 shortage resolution. Discuss the specifics with a qualified clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.